Natera EBITDA 2014-2025 | NTRA
Natera annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Natera EBITDA for the quarter ending March 31, 2025 was $-0.070B, a 3.78% increase year-over-year.
- Natera EBITDA for the twelve months ending March 31, 2025 was $-0.194B, a 45.5% decline year-over-year.
- Natera 2024 annual EBITDA was $-0.191B, a 54.51% decline from 2023.
- Natera 2023 annual EBITDA was $-0.42B, a 19% decline from 2022.
- Natera 2022 annual EBITDA was $-0.518B, a 15.71% increase from 2021.
| Natera Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-191 |
| 2023 | $-420 |
| 2022 | $-518 |
| 2021 | $-448 |
| 2020 | $-202 |
| 2019 | $-107 |
| 2018 | $-106 |
| 2017 | $-127 |
| 2016 | $-93 |
| 2015 | $-54 |
| 2014 | $6 |
| 2013 | $-23 |
| Natera Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-70 |
| 2024-12-31 | $-57 |
| 2024-09-30 | $-31 |
| 2024-06-30 | $-36 |
| 2024-03-31 | $-67 |
| 2023-12-31 | $-78 |
| 2023-09-30 | $-103 |
| 2023-06-30 | $-106 |
| 2023-03-31 | $-132 |
| 2022-12-31 | $-137 |
| 2022-09-30 | $-113 |
| 2022-06-30 | $-137 |
| 2022-03-31 | $-132 |
| 2021-12-31 | $-134 |
| 2021-09-30 | $-145 |
| 2021-06-30 | $-111 |
| 2021-03-31 | $-58 |
| 2020-12-31 | $-69 |
| 2020-09-30 | $-54 |
| 2020-06-30 | $-46 |
| 2020-03-31 | $-32 |
| 2019-12-31 | $-32 |
| 2019-09-30 | $-19 |
| 2019-06-30 | $-26 |
| 2019-03-31 | $-30 |
| 2018-12-31 | $-28 |
| 2018-09-30 | $-25 |
| 2018-06-30 | $-25 |
| 2018-03-31 | $-28 |
| 2017-12-31 | $-45 |
| 2017-09-30 | $-24 |
| 2017-06-30 | $-26 |
| 2017-03-31 | $-33 |
| 2016-12-31 | $-40 |
| 2016-09-30 | $-25 |
| 2016-06-30 | $-21 |
| 2016-03-31 | $-8 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-19 |
| 2015-06-30 | $-14 |
| 2015-03-31 | $-5 |
| 2014-12-31 | |
| 2014-09-30 | $6 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.934B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.035B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Caris Life Sciences,�Inc (CAI) | $6.821B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |